Pioneer transcription factors in cell reprogramming

Genes and Development

Volumn 28, Issue 24, 2014, Pages 2679-2692

  Iwafuchi Doi, Makiko ^a   Zaret, Kenneth S ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Chromatin; Development; Nucleosome; Pioneer transcription factor; Reprogramming; Transdifferentiation

Indexed keywords

TRANSCRIPTION FACTOR; CHROMATIN; NUCLEOSOME; PROTEIN BINDING;

CELL ACTIVITY; CELL FATE; CELL REPROGRAMMING; CELL TRANSDIFFERENTIATION; CELLS; CHROMATIN; CHROMATIN STRUCTURE; DEVELOPMENT; DISEASE COURSE; DNA BINDING; ENHANCER REGION; GENE ACTIVATION; GENOME; HETEROCHROMATIN; HUMAN; MITOSIS; NONHUMAN; NUCLEOSOME; PROCEDURES CONCERNING CELLS; REVIEW; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; NUCLEAR REPROGRAMMING;

EUKARYOTA;

CELL TRANSDIFFERENTIATION; CELLULAR REPROGRAMMING; CHROMATIN; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GENOME; NUCLEOSOMES; PROTEIN BINDING; TRANSCRIPTION FACTORS;

EID: 84918527386     PISSN: 08909369     EISSN: 15495477     Source Type: Journal    
DOI: 10.1101/gad.253443.114     Document Type: Review

References (121)

1. Adams CC, Workman JL. 1995. Binding of disparate transcriptional activators to nucleosomal DNA is inherently cooperative. Mol Cell Biol 15: 1405–1421.
2. Addis RC, Ifkovits JL, Pinto F, Kellam LD, Esteso P, Rentschler S, Christoforou N, Epstein JA, Gearhart JD. 2013. Optimization of direct fibroblast reprogramming to cardiomyocytes using calcium activity as a functional measure of success. J Mol Cell Cardiol 60: 97–106.
3. Anderson JD, Widom J. 2001. Poly(dA–dT) promoter elements increase the equilibrium accessibility of nucleosomal DNA target sites. Mol Cell Biol 21: 3830–3839.
4. Badve S, Turbin D, Thorat MA, Morimiya A, Nielsen TO, Perou CM, Dunn S, Huntsman DG, Nakshatri H. 2007. FOXA1 expression in breast cancer—correlation with luminal subtype A and survival. Clin Cancer Res 13: 4415–4421.
5. Addis RC, Ifkovits JL, Pinto F, Kellam LD, Esteso P, Rentschler S, Christoforou N, Epstein JA, Gearhart JD. 2013. Optimization of direct fibroblast reprogramming to cardiomyocytes using calcium activity as a functional measure of success. J Mol Cell Cardiol 60: 97–106.
6. Bass AJ, Watanabe H, Mermel CH, Yu S, Perner S, Verhaak RG, Kim SY, Wardwell L, Tamayo P, Gat-Viks I, et al. 2009. SOX2 is an amplified lineage-survival oncogene in lung and esophageal squamous cell carcinomas. Nat Genet 41: 1238–1242.
7. Berkes CA, Bergstrom DA, Penn BH, Seaver KJ, Knoepfler PS, Tapscott SJ. 2004. Pbx marks genes for activation by MyoD indicating a role for a homeodomain protein in establishing myogenic potential. Mol Cell 14: 465–477.
8. Bertrand N, Castro DS, Guillemot F. 2002. Proneural genes and the specification of neural cell types. Nat Rev Neurosci 3: 517–530.
9. Bort R, Signore M, Tremblay K, Barbera JP, Zaret KS. 2006. Hex homeobox gene controls the transition of the endoderm to a pseudostratified, cell emergent epithelium for liver bud development. Dev Biol 290: 44–56.
10. Bossard P, Zaret KS. 1998. GATA transcription factors as potentiators of gut endoderm differentiation. Development 125: 4909–4917.
11. Boumahdi S, Driessens G, Lapouge G, Rorive S, Nassar D, Le Mercier M, Delatte B, Caauwe A, Lenglez S, Nkusi E, et al. 2014. SOX2 controls tumour initiation and cancer stem-cell functions in squamous-cell carcinoma. Nature 511: 246–250.
12. Budry L, Balsalobre A, Gauthier Y, Khetchoumian K, L’Honore A, Vallette S, Brue T, Figarella-Branger D, Meij B, Drouin J. 2012. The selector gene Pax7 dictates alternate pituitary cell fates through its pioneer action on chromatin remodeling. Genes Dev 26: 2299–2310.
13. Buganim Y, Faddah DA, Cheng AW, Itskovich E, Markoulaki S, Ganz K, Klemm SL, van Oudenaarden A, Jaenisch R. 2012. Single-cell expression analyses during cellular reprogramming reveal an early stochastic and a late hierarchic phase. Cell 150: 1209–1222.
14. Buganim Y, Markoulaki S, van Wietmarschen N, Hoke H, Wu T, Ganz K, Akhtar-Zaidi B, He Y, Abraham BJ, Porubsky D, et al. 2014. The developmental potential of iPSCs is greatly influenced by reprogramming factor selection. Cell Stem Cell 15: 295–309.
15. Cahan P, Li H, Morris SA, Lummertz da Rocha E, Daley GQ, Collins JJ. 2014. CellNet: network biology applied to stem cell engineering. Cell 158: 903–915.
16. Caiazzo M, Dell’Anno MT, Dvoretskova E, Lazarevic D, Taverna S, Leo D, Sotnikova TD, Menegon A, Roncaglia P, Colciago G, et al. 2011. Direct generation of functional dopaminergic neurons from mouse and human fibroblasts. Nature 476: 224–227.
17. Caravaca JM, Donahue G, Becker JS, He X, Vinson C, Zaret KS. 2013. Bookmarking by specific and nonspecific binding of FoxA1 pioneer factor to mitotic chromosomes. Genes Dev 27: 251–260.
18. Carey M. 1998. The enhanceosome and transcriptional synergy. Cell 92: 5–8.
19. Carotta S, Wu L, Nutt SL. 2010. Surprising new roles for PU.1 in the adaptive immune response. Immunol Rev 238: 63–75.
20. Carroll JS, Liu XS, Brodsky AS, Li W, Meyer CA, Szary AJ, Eeckhoute J, Shao W, Hestermann EV, Geistlinger TR, et al. 2005. Chromosome-wide mapping of estrogen receptor binding reveals long-range regulation requiring the forkhead protein FoxA1. Cell 122: 33–43.
21. Chavez S, Beato M. 1997. Nucleosome-mediated synergism between transcription factors on the mouse mammary tumor virus promoter. Proc Natl Acad Sci 94: 2885–2890.
22. Chen J, Zhang Z, Li L, Chen BC, Revyakin A, Hajj B, Legant W, Dahan M, Lionnet T, Betzig E, et al. 2014. Single-molecule dynamics of enhanceosome assembly in embryonic stem cells. Cell 156: 1274–1285.
23. Cirillo LA, Zaret KS. 1999. An early developmental transcription factor complex that is more stable on nucleosome core particles than on free DNA. Mol Cell 4: 961–969.
24. Cirillo LA, McPherson CE, Bossard P, Stevens K, Cherian S, Shim E-Y, Clark EA, Burley SK, Zaret KS. 1998. Binding of the winged-helix transcription factor HNF3 to a linker histone site on the nucleosome. EMBO J 17: 244–254.
25. Cirillo L, Lin FR, Cuesta I, Jarnik M, Friedman D, Zaret K. 2002. Opening of compacted chromatin by early developmental transcription factors HNF3 (FOXA) and GATA-4. Mol Cell 9: 279–289.
26. Clark KL, Halay ED, Lai E, Burley SK. 1993. Co-crystal structure of the HNF3/fork head DNA recognition motif resembles histone H5. Nature 364: 412–420.
27. Clarke CL, Graham JD. 2012. Non-overlapping progesterone receptor cistromes contribute to cell-specific transcriptional outcomes. PLoS ONE 7: e35859.
28. Cruickshanks HA, McBryan T, Nelson DM, Vanderkraats ND, Shah PP, van Tuyn J, Singh Rai T, Brock C, Donahue G, Dunican DS, et al. 2013. Senescent cells harbour features of the cancer epigenome. Nat Cell Biol 15: 1495–1506.
29. Davis RL, Weintraub H, Lassar AB. 1987. Expression of a single transfected cDNA converts fibroblasts to myoblasts. Cell 51: 987–1000.
30. Drouin J. 2014. Minireview: pioneer transcription factors in cell fate specification. Mol Endocrinol 28: 989–998.
31. Egli D, Birkhoff G, Eggan K. 2008. Mediators of reprogramming: transcription factors and transitions through mitosis. Nat Rev Mol Cell Biol 9: 505–516.
32. Espinosa JM, Emerson BM. 2001. Transcriptional regulation by p53 through intrinsic DNA/chromatin binding and site-directed cofactor recruitment. Mol Cell 8: 57–69.
33. Fakhouri THI, Stevenson J, Chisholm AD, Mango SE. 2010. Dynamic chromatin organization during foregut development mediated by the organ selector gene PHA-4/FoxA. PLoS Genet 6: e1001060.
34. Feng R, Desbordes SC, Xie H, Tillo ES, Pixley F, Stanley ER, Graf T. 2008. PU.1 and C/EBPα/β convert fibroblasts into macrophage-like cells. Proc Natl Acad Sci 105: 6057–6062.
35. Feng B, Ng JH, Heng JC, Ng HH. 2009. Molecules that promote or enhance reprogramming of somatic cells to induced pluripotent stem cells. Cell Stem Cell 4: 301–312.
36. Foo SM, Sun Y, Lim B, Ziukaite R, O’Brien K, Nien CY, Kirov N, Shvartsman SY, Rushlow CA. 2014. Zelda potentiates morphogen activity by increasing chromatin accessibility. Curr Biol 24: 1341–1346.
37. Foygel K, Choi B, Jun S, Leong DE, Lee A, Wong CC, Zuo E, Eckart M, Reijo Pera RA, Wong WH, et al. 2008. A novel and critical role for Oct4 as a regulator of the maternal-embry-onic transition. PLoS ONE 3: e4109.
38. Gaffney DJ, McVicker G, Pai AA, Fondufe-Mittendorf YN, Lewellen N, Michelini K, Widom J, Gilad Y, Pritchard JK. 2012. Controls of nucleosome positioning in the human genome. PLoS Genet 8: e1003036.
39. Gao N, Zhang J, Rao MA, Case TC, Mirosevich J, Wang Y, Jin R, Gupta A, Rennie PS, Matusik RJ. 2003. The role of hepatocyte nuclear factor-3α (Forkhead box A1) and androgen receptor in transcriptional regulation of prostatic genes. Mol Endocrinol 17: 1484–1507.
40. Gao Y, Chen J, Li K, Wu T, Huang B, Liu W, Kou X, Zhang Y, Huang H, Jiang Y, et al. 2013. Replacement of Oct4 by Tet1 during iPSC induction reveals an important role of DNA methylation and hydroxymethylation in reprogramming. Cell Stem Cell 12: 453–469.
41. Ghisletti S, Barozzi I, Mietton F, Polletti S, De Santa F, Venturini E, Gregory L, Lonie L, Chew A, Wei CL, et al. 2010. Identification and characterization of enhancers controlling the inflammatory gene expression program in macrophages. Immunity 32: 317–328.
42. Gualdi R, Bossard P, Zheng M, Hamada Y, Coleman JR, Zaret KS. 1996. Hepatic specification of the gut endoderm in vitro: cell signaling and transcriptional control. Genes Dev 10: 1670– 1682.
43. Gurdon JB. 1962. The developmental capacity of nuclei taken from intestinal epithelium cells of feeding tadpoles. J Embryol Exp Morphol 10: 622–640.
44. Han J, Yuan P, Yang H, Zhang J, Soh BS, Li P, Lim SL, Cao S, Tay J, Orlov YL, et al. 2010. Tbx3 improves the germ-line competency of induced pluripotent stem cells. Nature 463: 1096– 1100.
45. Harrison MM, Li XY, Kaplan T, Botchan MR, Eisen MB. 2011. Zelda binding in the early Drosophila melanogaster embryo marks regions subsequently activated at the maternal-to-zygotic transition. PLoS Genet 7: e1002266.
46. Heinz S, Benner C, Spann N, Bertolino E, Lin YC, Laslo P, Cheng JX, Murre C, Singh H, Glass CK. 2010. Simple combinations of lineage-determining transcription factors prime cis-regulatory elements required for macrophage and B cell identities. Mol Cell 38: 576–589.
47. Ho JW, Jung YL, Liu T, Alver BH, Lee S, Ikegami K, Sohn KA, Minoda A, Tolstorukov MY, Appert A, et al. 2014. Comparative analysis of metazoan chromatin organization. Nature 512: 449–452.
48. Hochedlinger K, Plath K. 2009. Epigenetic reprogramming and induced pluripotency. Development 136: 509–523.
49. Holtzinger A, Evans T. 2005. Gata4 regulates the formation of multiple organs. Development 132: 4005–4014.
50. Huang P, He Z, Ji S, Sun H, Xiang D, Liu C, Hu Y, Wang X, Hui L. 2011. Induction of functional hepatocyte-like cells from mouse fibroblasts by defined factors. Nature 475: 386–389.
51. Ieda M, Fu JD, Delgado-Olguin P, Vedantham V, Hayashi Y, Bruneau BG, Srivastava D. 2010. Direct reprogramming of fibroblasts into functional cardiomyocytes by defined factors. Cell 142: 375–386.
52. Ioshikhes IP, Albert I, Zanton SJ, Pugh BF. 2006. Nucleosome positions predicted through comparative genomics. Nat Genet 38: 1210–1215.
53. Jozwik KM, Carroll JS. 2012. Pioneer factors in hormone-dependent cancers. Nat Rev Cancer 12: 381–385.
54. Kadauke S, Udugama MI, Pawlicki JM, Achtman JC, Jain DP, Cheng Y, Hardison RC, Blobel GA. 2012. Tissue-specific mitotic bookmarking by hematopoietic transcription factor GATA1. Cell 150: 725–737.
55. Kharchenko PV, Alekseyenko AA, Schwartz YB, Minoda A, Riddle NC, Ernst J, Sabo PJ, Larschan E, Gorchakov AA, Gu T, et al. 2011. Comprehensive analysis of the chromatin landscape in Drosophila melanogaster. Nature 471: 480–485.
56. Kornberg RD, Lorch Y. 1999. Twenty-five years of the nucleosome, fundamental particle of the eukaryote chromosome. Cell 98: 285–294.
57. Laptenko O, Beckerman R, Freulich E, Prives C. 2011. p53 binding to nucleosomes within the p21 promoter in vivo leads to nucleosome loss and transcriptional activation. Proc Natl Acad Sci 108: 10385–10390.
58. Lee CS, Friedman JR, Fulmer JT, Kaestner KH. 2005. The initiation of liver development is dependent on Foxa transcription factors. Nature 435: 944–947.
59. Lee MT, Bonneau AR, Takacs CM, Bazzini AA, DiVito KR, Fleming ES, Giraldez AJ. 2013. Nanog, Pou5f1 and SoxB1 activate zygotic gene expression during the maternal-to-zygotic transition. Nature 503: 360–364.
60. Leichsenring M, Maes J, Mossner R, Driever W, Onichtchouk D. 2013. Pou5f1 transcription factor controls zygotic gene activation in vertebrates. Science 341: 1005–1009.
61. Levine M, Cattoglio C, Tjian R. 2014. Looping back to leap forward: transcription enters a new era. Cell 157: 13–25.
62. Li Z, White P, Tuteja G, Rubins N, Sackett S, Kaestner KH. 2009. Foxa1 and Foxa2 regulate bile duct development in mice. J Clin Invest 119: 1537–1545.
63. Li Z, Gadue P, Chen K, Jiao Y, Tuteja G, Schug J, Li W, Kaestner KH. 2012a. Foxa2 and H2A.Z mediate nucleosome depletion during embryonic stem cell differentiation. Cell 151: 1608– 1616.
64. Li Z, Tuteja G, Schug J, Kaestner KH. 2012b. Foxa1 and Foxa2 are essential for sexual dimorphism in liver cancer. Cell 148: 72–83.
65. Liang HL, Nien CY, Liu HY, Metzstein MM, Kirov N, Rushlow C. 2008. The zinc-finger protein Zelda is a key activator of the early zygotic genome in Drosophila. Nature 456: 400– 403.
66. Lidor Nili E, Field Y, Lubling Y, Widom J, Oren M, Segal E. 2010. p53 binds preferentially to genomic regions with high DNA-encoded nucleosome occupancy. Genome Res 20: 1361–1368.
67. Lupien M, Eeckhoute J, Meyer CA, Wang Q, Zhang Y, Li W, Carroll JS, Liu XS, Brown M. 2008. FoxA1 translates epigenetic signatures into enhancer-driven lineage-specific transcription. Cell 132: 958–970.
68. Mahony S, Edwards MD, Mazzoni EO, Sherwood RI, Kakumanu A, Morrison CA, Wichterle H, Gifford DK. 2014. An integrated model of multiple-condition ChIP-seq data reveals predeterminants of Cdx2 binding. PLoS Comput Biol 10: e1003501.
69. Martinez-Balbas MA, Dey A, Rabindran SK, Ozato K, Wu C. 1995. Displacement of sequence-specific transcription factors from mitotic chromatin. Cell 83: 29–38.
70. McPherson CE, Shim E-Y, Friedman DS, Zaret KS. 1993. An active tissue-specific enhancer and bound transcription factors existing in a precisely postioned nucleosomal array. Cell 75: 387–398.
71. McPherson CE, Horowitz R, Woodcock CL, Jiang C, Zaret KS. 1996. Nucleosome positioning properties of the albumin transcriptional enhancer. Nucleic Acids Res 24: 397–404.
72. Menet JS, Pescatore S, Rosbash M. 2014. CLOCK:BMAL1 is a pioneer-like transcription factor. Genes Dev 28: 8–13.
73. Meshorer E, Yellajoshula D, George E, Scambler PJ, Brown DT, Misteli T. 2006. Hyperdynamic plasticity of chromatin proteins in pluripotent embryonic stem cells. Dev Cell 10: 105– 116.
74. Michelotti EF, Sanford S, Levens D. 1997. Marking of active genes on mitotic chromosomes. Nature 388: 895–899.
75. Miller JA, Widom J. 2003. Collaborative competition mechanism for gene activation in vivo. Mol Cell Biol 23: 1623– 1632.
76. Mirny LA. 2010. Nucleosome-mediated cooperativity between transcription factors. Proc Natl Acad Sci 107: 22534–22539.
77. Morris SA, Cahan P, Li H, Zhao AM, San Roman AK, Shivdasani RA, Collins JJ, Daley GQ. 2014. Dissecting engineered cell types and enhancing cell fate conversion via CellNet. Cell 158: 889–902.
78. Moyle-Heyrman G, Tims HS, Widom J. 2011. Structural constraints in collaborative competition of transcription factors against the nucleosome. J Mol Biol 412: 634–646.
79. Naumova N, Imakaev M, Fudenberg G, Zhan Y, Lajoie BR, Mirny LA, Dekker J. 2013. Organization of the mitotic chromosome. Science 342: 948–953.
80. Nien CY, Liang HL, Butcher S, Sun Y, Fu S, Gocha T, Kirov N, Manak JR, Rushlow C. 2011. Temporal coordination of gene networks by Zelda in the early Drosophila embryo. PLoS Genet 7: e1002339.
81. Pan H, Schultz RM. 2011. Sox2 modulates reprogramming of gene expression in two-cell mouse embryos. Biol Reprod 85: 409–416.
82. Pihlajamaa P, Sahu B, Lyly L, Aittomaki V, Hautaniemi S, Janne OA. 2014. Tissue-specific pioneer factors associate with androgen receptor cistromes and transcription programs. EMBO J 33: 312–326.
83. Ptashne M. 2011. Principles of a switch. Nat Chem Biol 7: 484– 487.
84. Ramakrishnan V, Finch JT, Graziano V, Lee PL, Sweet RM. 1993. Crystal structure of globular domain of histone H5 and its implications for nucleosome binding. Nature 362: 219–224.
85. Sch€afer BW, Blakely BT, Darlington GJ, Blau HM. 1990. Effect of cell history on response to helix–loop–helix family of myogenic regulators. Nature 344: 454–459.
86. Schones DE, Cui K, Cuddapah S, Roh TY, Barski A, Wang Z, Wei G, Zhao K. 2008. Dynamic regulation of nucleosome positioning in the human genome. Cell 132: 887–898.
87. Segal E, Fondufe-Mittendorf Y, Chen L, Thastrom A, Field Y, Moore IK, Wang JP, Widom J. 2006. A genomic code for nucleosome positioning. Nature 442: 772–778.
88. Sekiya S, Suzuki A. 2011. Direct conversion of mouse fibroblasts to hepatocyte-like cells by defined factors. Nature 475: 390–393.
89. Sekiya T, Zaret KS. 2007. Repression by Groucho/TLE/Grg proteins: genomic site recruitment generates compacted chromatin in vitro and impairs activator binding in vivo. Mol Cell 28: 291–303.
90. Serandour AA, Avner S, Percevault F, Demay F, Bizot M, Lucchetti-Miganeh C, Barloy-Hubler F, Brown M, Lupien M, Metivier R, et al. 2011. Epigenetic switch involved in activation of pioneer factor FOXA1-dependent enhancers. Genome Res 21: 555–565.
91. Sherwood RI, Hashimoto T, O’Donnell CW, Lewis S, Barkal AA, van Hoff JP, Karun V, Jaakkola T, Gifford DK. 2014. Discovery of directional and nondirectional pioneer transcription factors by modeling DNase profile magnitude and shape. Nat Biotechnol 32: 171–178.
92. Shim EY, Woodcock C, Zaret KS. 1998. Nucleosome positioning by the winged-helix transcription factor HNF3. Genes Dev 12: 5–10.
93. Son EY, Ichida JK, Wainger BJ, Toma JS, Rafuse VF, Woolf CJ, Eggan K. 2011. Conversion of mouse and human fibroblasts into functional spinal motor neurons. Cell Stem Cell 9: 205– 218.
94. Soufi A, Donahue G, Zaret KS. 2012. Facilitators and impediments of the pluripotency reprogramming factors’ initial engagement with the genome. Cell 151: 994–1004.
95. Struhl K. 1999. Fundamentally different logic of gene regulation in eukaryotes and prokaryotes. Cell 98: 1–4.
96. Struhl K, Segal E. 2013. Determinants of nucleosome positioning. Nat Struct Mol Biol 20: 267–273.
97. Tadros W, Lipshitz HD. 2009. The maternal-to-zygotic transition: a play in two acts. Development 136: 3033–3042.
98. Takahashi K, Yamanaka S. 2006. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126: 663–676.
99. Taube JH, Allton K, Duncan SA, Shen L, Barton MC. 2010. Foxa1 functions as a pioneer transcription factor at transposable elements to activate Afp during differentiation of embryonic stem cells. J Biol Chem 285: 16135–16144.
100. Teif VB, Vainshtein Y, Caudron-Herger M, Mallm JP, Marth C, Hofer T, Rippe K. 2012. Genome-wide nucleosome positioning during embryonic stem cell development. Nat Struct Mol Biol 19: 1185–1192.
101. Thurman RE, Rynes E, Humbert R, Vierstra J, Maurano MT, Haugen E, Sheffield NC, Stergachis AB, Wang H, Vernot B, et al. 2012. The accessible chromatin landscape of the human genome. Nature 489: 75–82.
102. Tillo D, Hughes TR. 2009. G+C content dominates intrinsic nucleosome occupancy. BMC Bioinformatics 10: 442.
103. Tillo D, Kaplan N, Moore IK, Fondufe-Mittendorf Y, Gossett AJ, Field Y, Lieb JD, Widom J, Segal E, Hughes TR. 2010. High nucleosome occupancy is encoded at human regulatory sequences. PLoS ONE 5: e9129.
104. Updike DL, Mango SE. 2006. Temporal regulation of foregut development by HTZ-1/H2A.Z and PHA-4/FoxA. PLoS Genet 2: e161.
105. Valouev A, Johnson SM, Boyd SD, Smith CL, Fire AZ, Sidow A. 2011. Determinants of nucleosome organization in primary human cells. Nature 474: 516–520.
106. Vashee S, Melcher K, Ding WV, Johnston SA, Kodadek T. 1998. Evidence for two modes of cooperative DNA binding in vivo that do not involve direct protein–protein interactions. Curr Biol 8: 452–458.
107. Vierbuchen T, Ostermeier A, Pang ZP, Kokubu Y, Sudhof TC, Wernig M. 2010. Direct conversion of fibroblasts to functional neurons by defined factors. Nature 463: 1035–1041.
108. Wang X, Bai L, Bryant GO, Ptashne M. 2011. Nucleosomes and the accessibility problem. Trends Genet 27: 487–492.
109. Wang S, Linde MH, Munde M, Carvalho VD, Wilson WD, Poon GM. 2014. Mechanistic heterogeneity in site recognition by the structurally homologous DNA-binding domains of the ETS family transcription factors Ets-1 and PU.1. J Biol Chem 289: 21605–21616.
110. Wapinski OL, Vierbuchen T, Qu K, Lee QY, Chanda S, Fuentes DR, Giresi PG, Ng YH, Marro S, Neff NF, et al. 2013. Hierarchical mechanisms for direct reprogramming of fibroblasts to neurons. Cell 155: 621–635.
111. Watt AJ, Zhao R, Li J, Duncan SA. 2007. Development of the mammalian liver and ventral pancreas is dependent on GATA4. BMC Dev Biol 7: 37.
112. Weintraub H, Tapscott SJ, Davis RL, Thayer MJ, Adam MA, Lassar AB, Miller AD. 1989. Activation of muscle-specific genes in pigment, nerve, fat, liver, and fibroblast cell lines by forced expression of MyoD. Proc Natl Acad Sci 86: 5434– 5438.
113. Xu C, Lu X, Chen EZ, He Z, Uyunbilig B, Li G, Ma Y, Hui L, Xie B, Gao Y, et al. 2012. Genome-wide roles of Foxa2 in directing liver specification. J Mol Cell Biol 4: 420–422.
114. Xu Z, Chen H, Ling J, Yu D, Struffi P, Small S. 2014. Impacts of the ubiquitous factor Zelda on Bicoid-dependent DNA binding and transcription in Drosophila. Genes Dev 28: 608–621.
115. Yamamoto KR. 1985. Steroid receptor regulated transcription of specific genes and gene networks. Annu Rev Genet 19: 209– 252.
116. Yu J, Vodyanik MA, Smuga-Otto K, Antosiewicz-Bourget J, Frane JL, Tian S, Nie J, Jonsdottir GA, Ruotti V, Stewart R, et al. 2007. Induced pluripotent stem cell lines derived from human somatic cells. Science 318: 1917–1920.
117. Zaidi SK, Young DW, Montecino MA, Lian JB, van Wijnen AJ, Stein JL, Stein GS. 2010. Mitotic bookmarking of genes: a novel dimension to epigenetic control. Nat Rev Genet 11: 583–589.
118. Zaret KS. 2014. Genome reactivation after the silence in mitosis: recapitulating mechanisms of development? Dev Cell 29: 132–134.
119. Zaret K., Carroll JS. 2011. Pioneer transcription factors: establishing competence for gene expression. Genes Dev 25: 2227–2241.
120. Zhang L, Rubins NE, Ahima RS, Greenbaum LE, Kaestner KH. 2005. Foxa2 integrates the transcriptional response of the hepatocyte to fasting. Cell Metab 2: 141–148.
121. Zhao R, Watt AJ, Li J, Luebke-Wheeler J, Morrisey EE, Duncan SA. 2005. GATA6 is essential for embryonic development of the liver but dispensable for early heart formation. Mol Cell Biol 25: 2622–2631.